RegiSCAR study group | Japanese consensus group | Bocquet et al. |
---|---|---|
More than 3 of the criteria are required for the diagnosis of DRESS: 1. Hospitalization 2. Reaction suspected to be drug related 3. Acute rash 4. Fever above 38 °C 5. Enlarged lymph nodes involving at least two sites 6. Involvement of at least one internal organ 7. Blood count abnormalities: Lymphocytes above or below laboratory limits, Eosinophils above laboratory limits (in percentage or absolute count), Platelets below laboratory limits | Typical DRESS (presence of all 7 criteria); atypical DIHS (all criteria present except lymphadenopathy and HHV-6 reactivation): 1. HHV-6 reactivation 2. Prolonged clinical symptoms 2 weeks after discontinuation of causative drug 3. Maculopapular rash developing > 3 weeks after starting drug 4. Fever above 38 °C 5. Lymphadenopathy 6. ALT > 100 U/L or other organ involvement 7. Leukocyte abnormalities (at least one): Leukocytosis (> 11 × 109/L), Atypical lymphocytosis (> 5%), Eosinophilia (1.5 × 109/L) | DRESS is confirmed by presence of 3 criteria: 1. Cutaneous drug eruption 2. Adenopathies > 2 cm in diameter or hepatitis (liver transaminases > 2 times upper limit of normal) (or) interstitial nephritis (or) interstitial pneumonitis (or) carditis 3. Hematologic abnormalities eosinophilia > 1.5 × 109/L (or) atypical lymphocytes |